JP4529402B2 - Skin cosmetics - Google Patents
Skin cosmetics Download PDFInfo
- Publication number
- JP4529402B2 JP4529402B2 JP2003339024A JP2003339024A JP4529402B2 JP 4529402 B2 JP4529402 B2 JP 4529402B2 JP 2003339024 A JP2003339024 A JP 2003339024A JP 2003339024 A JP2003339024 A JP 2003339024A JP 4529402 B2 JP4529402 B2 JP 4529402B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- effect
- acid
- fatty acid
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 41
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 26
- 229930195729 fatty acid Natural products 0.000 claims description 26
- -1 fatty acid butylene oxide Chemical class 0.000 claims description 22
- 150000004665 fatty acids Chemical class 0.000 claims description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 41
- 230000003020 moisturizing effect Effects 0.000 description 24
- 230000037303 wrinkles Effects 0.000 description 22
- 206010013786 Dry skin Diseases 0.000 description 13
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 11
- 230000001629 suppression Effects 0.000 description 11
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 4
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229960003720 enoxolone Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002350 guaiazulen Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000007788 roughening Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GELKGHVAFRCJNA-UHFFFAOYSA-N 2,2-Dimethyloxirane Chemical compound CC1(C)CO1 GELKGHVAFRCJNA-UHFFFAOYSA-N 0.000 description 1
- PQXKWPLDPFFDJP-UHFFFAOYSA-N 2,3-dimethyloxirane Chemical compound CC1OC1C PQXKWPLDPFFDJP-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- ACEWLPOYLGNNHV-UHFFFAOYSA-N Ibuprofen piconol Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000001545 azulenes Chemical class 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229950005954 ibuprofen piconol Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 239000008308 lipophilic cream Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- YLSUMFQEBHBMQB-OOFFSTKBSA-M potassium;(2s,3s,4s,5r,6s)-6-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-5-[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3,4-dihydrox Chemical compound [K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O YLSUMFQEBHBMQB-OOFFSTKBSA-M 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 108090000623 proteins and genes Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は化粧水、乳液、クリーム、パック、ヘアトニック等の皮膚用の化粧料に関し、さらに詳しくは使用時の感触が軽く素早く肌になじみ、使用後にべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、肌にはりを与えて経時安定性に優れる等の効果を有する皮膚化粧料に関する。 The present invention relates to cosmetics for skin such as lotions, emulsions, creams, packs, hair tonics, and more specifically, feels light and quickly adapts to the skin, does not become sticky after use, and has excellent durability of the moisturizing effect. The present invention relates to a skin cosmetic that has an effect of improving skin roughness, an effect of suppressing wrinkles, and has an effect of giving skin elasticity and excellent stability over time.
人の皮膚表面は皮脂膜に覆われていて水分の蒸散が適度に抑制されている。そして、皮膚の水分を適切な範囲に保つことは皮膚の健康の面から見て非常に大切なことであり、水分が不足すると肌荒れ等を生じやすくなる。特に洗顔や入浴を行うと一時的に皮脂膜が取り除かれてしまい肌の水分が失われやすくなることから、化粧水、乳液、クリーム、美容液等の化粧料を使用して水分を補う必要がある。一般にこれらの化粧料には保湿剤としてグリセリン、1,3−ブチレングリコール、ソルビトール等の多価アルコール類やピロリドンカルボン酸塩等が配合されている。これらの保湿剤は高湿度下における水分保持力には優れているものの低湿度下における水分保持力に難があり、保湿効果の持続性が保てないばかりでなく、場合により皮膚の水分を吸収することから逆に肌荒れを促進させることがあった。
そこで近年、低湿度下での水分保持力の高い保湿成分としてキチン、キトサン及びそれらの誘導体、蛋白加水分解物、ヒアルロン酸等の酸性ムコ多糖類、植物抽出物等種々の高保湿成分が研究されている。しかし、これらの保湿成分を化粧料に配合するとその高い保湿力から不快なべたつきを有するという欠点があった。そこで、高い保湿効果を保持しながらべたつきを改善したものとして、例えばムコ多糖類とトレハロースとを組み合わせた皮膚外用剤(特許文献1)等があるが、いまだ十分にべたつきを抑えることはできず、しかも使用時ののび、肌へのなじみ性、肌荒れ防止及び改善効果、肌にはりを与える効果、しわ抑制効果等に関して十分な性能が得られていなかった。
一方、皮膚化粧料の重要な機能として肌荒れの防止及び改善効果が挙げられる。特にこの機能を付与させる為にはこのような保湿剤とともに油分を配合することが有効であることから、皮膚化粧料は乳液、クリーム、美容液等の乳化した剤形により使用されることが多い。しかし、油分を使用した製品では使用時ののびが悪くなったりベタツキを生じたりすることが多く、これらを解決することが困難であるという問題があった。さらに、この機能強化を目的として保湿効果の高い成分やビタミン類とともにグリチルリチン酸塩やグリチルレチン酸誘導体、アズレン誘導体等種々の抗炎症剤を配合する皮膚化粧料や皮膚外用剤も試みられている(特許文献2〜5)。しかし、良好な使用感を有しつつ十分な肌荒れの防止、改善効果を有する化粧料は得られていないのが現状であり、しかも、加齢や紫外線等に起因するしわの生成を効果的に抑制したり改善するとともに肌をなめらかにしてはりとうるおいのある若々しい肌に整えるといった、いわゆる皮膚の老化防止の効果を十分併せ持つ化粧料は得られていなかった。
The surface of human skin is covered with a sebum film, and moisture transpiration is moderately suppressed. Keeping the skin moisture within an appropriate range is very important from the viewpoint of skin health. If the moisture is insufficient, rough skin and the like are likely to occur. Especially when face washing and bathing, the sebum film is temporarily removed and the moisture of the skin is easily lost, so it is necessary to supplement the moisture with cosmetics such as lotion, milky lotion, cream, beauty serum, etc. is there. In general, these cosmetics contain polyhydric alcohols such as glycerin, 1,3-butylene glycol and sorbitol, pyrrolidone carboxylate, and the like as moisturizers. These moisturizers are excellent in moisture retention under high humidity, but have difficulty in moisture retention under low humidity, not only cannot maintain the moisturizing effect, but also absorb skin moisture in some cases. On the contrary, it sometimes promotes rough skin.
Therefore, in recent years, various high moisturizing ingredients such as chitin, chitosan and their derivatives, protein hydrolysates, acidic mucopolysaccharides such as hyaluronic acid, plant extracts, etc., have been studied as moisturizing ingredients with high moisture retention at low humidity. ing. However, when these moisturizing ingredients are blended in cosmetics, there is a drawback that they have an unpleasant stickiness due to their high moisturizing power. Therefore, as an example of improving the stickiness while maintaining a high moisturizing effect, there is, for example, a skin external preparation that combines mucopolysaccharide and trehalose (Patent Document 1), but still cannot sufficiently suppress stickiness, In addition, sufficient performance has not been obtained with respect to spreading during use, conformability to the skin, skin roughening prevention and improvement effect, skin-growth effect, wrinkle suppression effect, and the like.
On the other hand, an important function of skin cosmetics is prevention and improvement of rough skin. In particular, in order to impart this function, it is effective to blend an oil with such a moisturizing agent, so skin cosmetics are often used in an emulsified dosage form such as a milky lotion, a cream, or a cosmetic liquid. . However, products using oil often suffer from poor spread and stickiness during use, and there is a problem that it is difficult to solve these problems. Furthermore, for the purpose of enhancing this function, skin cosmetics and external preparations for skin containing various anti-inflammatory agents such as glycyrrhizinate, glycyrrhetinic acid derivatives and azulene derivatives together with ingredients and vitamins with high moisturizing effect have been tried (patents). Literature 2-5). However, it is the current situation that cosmetics that have a good feeling of use but have sufficient skin roughness prevention and improvement effects have not been obtained, and moreover, wrinkles due to aging, ultraviolet rays, etc. are effectively generated There has not been obtained a cosmetic that sufficiently suppresses or improves the skin and smoothes the skin to make the skin smooth and moisturized, and also has a so-called anti-aging effect on the skin.
本発明は、使用時の感触が軽く素早く肌になじみ、使用後にべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、肌にはりを与えて経時安定性に優れる等の効果を有し、好ましくはその全ての効果を併せ有する皮膚化粧料を提供することを目的とする。 The present invention is light and feels comfortable when used, does not become sticky after use, has excellent moisturizing effect, has excellent skin roughness improvement effect, wrinkle suppression effect, gives skin elasticity and has excellent temporal stability, etc. It is an object of the present invention to provide a skin cosmetic that has the following effects, and preferably has all the effects.
上記課題を解決する為に研究を重ねたところ、特定の脂肪酸ブチレンオキシド付加物と特定の多価アルコールを特定の割合で組み合わせた皮膚化粧料を用いることで上記課題を解決しうることを見出し本発明に至った。
すなわち本発明は、
(1)(a)炭素数10〜20の脂肪酸に対してブチレンオキシドを0.8〜1.4のモル比で反応して得られる脂肪酸ブチレンオキシド付加物を0.01〜50重量%、及び(b)炭素数2〜6の2価アルコールを0.1〜30重量%含有し、上記(a)成分と(b)成分の含有割合(a/b)が重量比で1/100〜10/1である皮膚化粧料、及び
(2)更に(c)ビタミンE、その誘導体及び抗炎症剤から選ばれる少なくとも一種を0.001〜5重量%含有する上記(1)の皮膚化粧料、である。
As a result of repeated research to solve the above problems, it was found that the above problems can be solved by using a skin cosmetic that combines a specific fatty acid butylene oxide adduct and a specific polyhydric alcohol in a specific ratio. Invented.
That is, the present invention
(1) (a) 0.01 to 50% by weight of a fatty acid butylene oxide adduct obtained by reacting butylene oxide with a molar ratio of 0.8 to 1.4 to a fatty acid having 10 to 20 carbon atoms, and (B) It contains 0.1 to 30% by weight of a dihydric alcohol having 2 to 6 carbon atoms, and the content ratio (a / b) of the component (a) to the component (b) is 1/100 to 10 by weight. And (2) the skin cosmetic composition according to (1), further comprising (c) 0.001 to 5% by weight of at least one selected from vitamin E, a derivative thereof, and an anti-inflammatory agent. is there.
本発明の皮膚化粧料は、以下のような効果を奏する。
(1)少なくとも、保湿効果の持続性及び肌荒れ改善効果に優れる。
(2)保湿効果の持続性及び肌荒れ改善効果に優れ、かつ使用後のべたつき抑制効果あるいはしわ抑制効果に優れる。
(3)使用時の感触が良好で、保湿効果の持続性及び肌荒れ改善効果に優れ、かつ使用後のべたつき抑制効果あるいはしわ抑制効果に優れる。
(4)使用時の感触が軽く、素早く肌になじむとともに、使用後もべたつかず、また保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、更に肌にはりを与えて経時安定性にも優れる。
The skin cosmetic of the present invention has the following effects.
(1) At least, it has excellent moisturizing effect and skin roughness improvement effect.
(2) Excellent moisturizing effect persistence and rough skin improving effect, and excellent stickiness suppressing effect or wrinkle suppressing effect after use.
(3) The touch at the time of use is good, the durability of the moisturizing effect and the effect of improving the rough skin are excellent, and the sticky suppressing effect or the wrinkle suppressing effect after use is excellent.
(4) It feels light when used, quickly adapts to the skin, does not become sticky after use, has excellent moisturizing effect, has excellent skin roughness improvement effect, wrinkle suppression effect, and gives skin firmness and stable over time Excellent in properties.
以下、本発明を詳細に説明する。
本発明の皮膚化粧料に用いられる(a)成分の脂肪酸ブチルオキシド付加物は、炭素数10〜20の脂肪酸(FA)とブチレンオキシド(BO)とを、BO/FAモル比で0.8〜1.4の割合で反応して得られる。
炭素数10〜20の脂肪酸としては、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、アラキジン酸や、これらの混合物であるヤシ油脂肪酸、パーム油脂肪酸等が挙げられる。
ブチレンオキシドとしては、1,2−ブチレンオキシド、2,3−ブチレンオキシド、イソブチレンオキシドが挙げられるが、入手のし易さ、反応制御のし易さ等の面から1,2−ブチレンオキシドが好ましい。
Hereinafter, the present invention will be described in detail.
The fatty acid butyl oxide adduct of the component (a) used in the skin cosmetic of the present invention comprises a fatty acid (FA) having 10 to 20 carbon atoms and butylene oxide (BO) in a BO / FA molar ratio of 0.8 to It is obtained by reacting at a ratio of 1.4.
Examples of the fatty acid having 10 to 20 carbon atoms include capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, arachidic acid, and coconut oil fatty acid and palm oil fatty acid which are a mixture thereof. It is done.
Examples of the butylene oxide include 1,2-butylene oxide, 2,3-butylene oxide, and isobutylene oxide, but 1,2-butylene oxide is preferable from the viewpoint of easy availability and easy reaction control. .
炭素数10〜20の脂肪酸とブチレンオキシドの反応モル比は0.8〜1.4であり、好ましくは1.0〜1.3である。本反応は、上記脂肪酸に、触媒の存在下昇温した後ブチレンオキシドを添加し付加反応させることによって行われる。触媒としては、相関移動触媒、ルイス酸触媒、アルカリ触媒等を用いることができ、中でも相関移動触媒、具体的にはテトラメチルアンモニウムクロライド等の四級アンモニウム塩、オニウム塩等を使用することが好ましい。
(a)成分の化粧料中の含有量は0.01〜50重量%であり、好ましくは0.02〜40重量%であり、更に好ましくは0.05〜35重量%である。0.01重量%未満では肌荒れ改善効果、しわ抑制効果が弱くなり、50重量%を超えると使用時の感触が重く、使用後のべたつき感が強くなり、経時安定性に問題を生じる。
The reaction molar ratio of the fatty acid having 10 to 20 carbon atoms and butylene oxide is 0.8 to 1.4, preferably 1.0 to 1.3. This reaction is carried out by adding butylene oxide to the above fatty acid after heating in the presence of a catalyst, followed by addition reaction. As the catalyst, a phase transfer catalyst, a Lewis acid catalyst, an alkali catalyst, or the like can be used. Among them, a phase transfer catalyst, specifically, a quaternary ammonium salt such as tetramethylammonium chloride, an onium salt, or the like is preferably used. .
The content of the component (a) in the cosmetic is 0.01 to 50% by weight, preferably 0.02 to 40% by weight, and more preferably 0.05 to 35% by weight. If it is less than 0.01% by weight, the effect of improving skin roughness and the effect of suppressing wrinkles are weakened. If it exceeds 50% by weight, the feeling during use is heavy, the feeling of stickiness after use becomes strong, and there is a problem in stability over time.
本発明の化粧料に使用される(b)成分の炭素数2〜6の2価アルコールは、水溶性多価アルコールであり、分子内に不飽和結合やエーテル結合、エステル結合等を有していても良く、例えば、プロピレングリコール、1,3−ブタンジオール、1,2−ペンタンジオール、ジエチレングリコール、トリエチレングリコール、ジプロピレングリコール等が使用できる。 The (b) component C2-C6 dihydric alcohol used in the cosmetic of the present invention is a water-soluble polyhydric alcohol, and has an unsaturated bond, an ether bond, an ester bond, etc. in the molecule. For example, propylene glycol, 1,3-butanediol, 1,2-pentanediol, diethylene glycol, triethylene glycol, dipropylene glycol and the like can be used.
(b)成分の化粧料中の含有量は0.1〜30重量%であり、好ましくは0.1〜25重量%、更に好ましくは0.5〜20重量%である。0.1重量%未満では肌荒れ改善効果、保湿効果の持続性、しわ抑制効果が弱くなり、30重量%を超えるとのびが悪くなったり、べたつき感が強くなる。
また、本発明においては(a)成分と(b)成分の含有割合(a/b)は重量比で1/100〜10/1であり、好ましくは1/50〜5/1である。a/bが1/100未満の場合は、肌荒れ改善効果、しわ抑制効果が弱くなり、10/1超える場合は、保湿効果の持続性が悪くなるとともに肌へのなじみ性が悪くなる。
The content of the component (b) in the cosmetic is 0.1 to 30% by weight, preferably 0.1 to 25% by weight, and more preferably 0.5 to 20% by weight. If it is less than 0.1% by weight, the effect of improving the rough skin, the durability of the moisturizing effect, and the effect of suppressing wrinkles are weakened.
Moreover, in this invention, the content rate (a / b) of (a) component and (b) component is 1 / 100-10 / 1 by weight ratio, Preferably it is 1 / 50-5 / 1. When a / b is less than 1/100, the effect of improving skin roughness and the effect of suppressing wrinkles are weakened, and when it exceeds 10/1, the durability of the moisturizing effect is deteriorated and the conformability to the skin is deteriorated.
本発明においてはしわ抑制効果、肌荒れ改善効果、および肌にはりを与える効果をさらに高めるためにc成分のビタミンE、その誘導体及び/又は抗炎症剤を添加することができる。
ビタミンEは別名トコフェロールとして知られる脂溶性ビタミンであり、α体、β体、γ体、δ体のいずれも使用できる。その誘導体としては酢酸、燐酸、硫酸等の酸とのエステルやアルコールとのエーテル等がある。本発明においては、トコフェロールもしくはその酢酸エステルが好ましく使用できる。
In the present invention, vitamin C as a component c, a derivative thereof and / or an anti-inflammatory agent can be added in order to further enhance the effect of suppressing wrinkles, the effect of improving rough skin, and the effect of giving skin flesh.
Vitamin E is a fat-soluble vitamin also known as tocopherol, and any of α-form, β-form, γ-form and delta-form can be used. The derivatives include esters with acids such as acetic acid, phosphoric acid and sulfuric acid, ethers with alcohols, and the like. In the present invention, tocopherol or an acetate thereof can be preferably used.
抗炎症剤としては、例えばグリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体、グアイアズレン、インドメタシン、ケトプロフェン、ピロシキカム、アセトアミノフェン、アスピリン、サリチル酸、ブフェマキサク、スプロフェン、イブプロフェンピコノール、フルルビプロフェン、プラノプロフェン、ジクロフェナクナトリム、サリチル酸ナトリウム、ベンザダック、フェルビナク、ウフェルナマート、ヒドロコルチゾン、プレドニゾロン等が挙げられる。その中でも好ましいものは、グリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体、グアイアズレンから選ばれる1種または2種以上であり、更に好ましくはグリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体から選ばれる1種または2種以上である。グリチルリチン酸の誘導体としてはグリチルリチン酸ジカリウム、グリチルリチン酸モノカリウム、グリチルリチン酸モノアンモニウム等が挙げられ、グリチルレチン酸の誘導体としてはグリチルレチン酸ステアリル、グリチルレチン酸グリチルレチニル3−サクシニルオキシグリチルレチン酸ニナトリウム等があり、アラントインの誘導体としてはアラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウム等が挙げられる。 Anti-inflammatory agents include, for example, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, allantoin and its derivatives, guaiazulene, indomethacin, ketoprofen, pirosiquicam, acetaminophen, aspirin, salicylic acid, buphemaxac, suprofen, ibuprofen piconol, flurbi Prophen, pranoprofen, diclofenacnatrim, sodium salicylate, benzadac, felbinac, ufernamate, hydrocortisone, prednisolone and the like. Among them, preferred are glycyrrhizic acid and derivatives thereof, glycyrrhetinic acid and derivatives thereof, allantoin and derivatives thereof, and one or more selected from guaiazulene, more preferably glycyrrhizic acid and derivatives thereof, glycyrrhetinic acid and derivatives thereof. , One or more selected from allantoin and derivatives thereof. Derivatives of glycyrrhizic acid include dipotassium glycyrrhizinate, monopotassium glycyrrhizinate, monoammonium glycyrrhizinate, etc., and derivatives of glycyrrhetinic acid include stearyl glycyrrhetinate, glycyrrhetinic acid glycyrrhetinate 3-succinyloxyglycyrrhetinate, and allantoin Examples of the derivatives include allantoinchlorohydroxyaluminum and allantoindihydroxyaluminum.
(c)成分の含有量は0.001〜5重量であることが好ましく、更に好ましくは0.01〜3重量%である。0.001重量%以上であれば肌荒れ改善効果に優れ、5重量%以下の場合は、のびが良く、べたつきが抑制され、保存安定性も良好であり、またコスト的にも有利である。 (C) It is preferable that content of a component is 0.001-5 weight, More preferably, it is 0.01-3 weight%. If it is 0.001% by weight or more, the effect of improving skin roughness is excellent, and if it is 5% by weight or less, it has good spreading, stickiness is suppressed, storage stability is good, and cost is advantageous.
本発明の皮膚化粧料には、上記各成分に加え、以下の添加剤を配合することも可能である。すなわち、エタノール、イソプロピルアルコール等の低級アルコール、グリセリン、ジグリセリン、ポリエチレングリコール、ソルビトール等の(b)成分以外の多価アルコール類、流動パラフィン、流動イソパラフィン、スクワラン、ワセリン、固形パラフィン等の炭化水素系油、牛脂、豚脂、魚油等の天然油脂類、トリ2−エチルヘキサン酸グリセリル等の合成トリグリセライド、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸セチル、オレイン酸エチル、オレイン酸オレイル、ミリスチン酸オクチルドデシル等のエステル油、ミツロウ、カルナバロウ等のロウ類、ジメチルポリシロキサン、テトラメチルペンタシクロシロキサン、ポリエーテル変性ジメチルポリシロキサン、アミノ変性ジメチルポリシロキサン等のシリコーン誘導体、セラミド、コレステロール、蛋白誘導体、ラノリン、ラノリン誘導体、レシチン等の油性基剤、石鹸、アシルメチルタウリン塩、アミドエーテル硫酸エステル塩等の陰イオン性界面活性剤、アミドアミノ酸塩、アミドプロピルジメチルアミノ酢酸ベタイン等の両性界面活性剤、ポリオキシエチレンアルキルエーテル、ポリエチレングリコールの脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ひまし油、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、グリセリンモノ脂肪酸エステル、アルキルポリグルコシド、アルカノールアミド等の非イオン性界面活性剤、塩化アルキルトリメチルアンモニウム等の陽イオン性界面活性剤、アルキルジメチルアミンオキシド等の半極性界面活性剤、アルギン酸、カルボキシビニルポリマー、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、キサンタンガム等の水溶性高分子、ピロリドンカルボン酸塩、クエン酸塩、リンゴ酸塩、食塩等の有機または無機塩類、pH調製剤である酸及びアルカリ、殺菌剤、キレート剤、抗酸化剤、紫外線吸収剤、動植物由来の天然エキス、色素、顔料及び香料等を配合できる。 In addition to the above-mentioned components, the following additives can be added to the skin cosmetic of the present invention. That is, hydrocarbons such as lower alcohols such as ethanol and isopropyl alcohol, polyhydric alcohols other than component (b) such as glycerin, diglycerin, polyethylene glycol, sorbitol, liquid paraffin, liquid isoparaffin, squalane, petrolatum, solid paraffin, etc. Natural fats and oils, beef tallow, pork fat, fish oil, synthetic triglycerides such as glyceryl tri-2-ethylhexanoate, isopropyl myristate, isopropyl palmitate, cetyl palmitate, ethyl oleate, oleyl oleate, octyldodecyl myristate Ester oils, waxes such as beeswax and carnauba wax, dimethylpolysiloxane, tetramethylpentacyclosiloxane, polyether-modified dimethylpolysiloxane, amino-modified dimethylpolysiloxane Silicone derivatives, ceramides, cholesterols, protein derivatives, lanolin, lanolin derivatives, oily bases such as lecithin, anionic surfactants such as soaps, acylmethyl taurine salts, amide ether sulfates, amide amino acid salts, amidopropyl Amphoteric surfactants such as dimethylaminoacetic acid betaine, polyoxyethylene alkyl ether, fatty acid ester of polyethylene glycol, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid Nonionic surfactants such as esters, glycerin monofatty acid esters, alkylpolyglucosides, alkanolamides, and cations such as alkyltrimethylammonium chloride Surfactant, semipolar surfactant such as alkyldimethylamine oxide, water-soluble polymer such as alginic acid, carboxyvinyl polymer, carboxymethylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, xanthan gum, pyrrolidone carboxylate, citrate, apple Organic or inorganic salts such as acid salts and salt, acids and alkalis that are pH adjusting agents, bactericides, chelating agents, antioxidants, ultraviolet absorbers, natural extracts derived from animals and plants, dyes, pigments and fragrances can be blended.
次に、実施例により本発明を更に具体的に説明する。
実施例1〜3及び比較例1、2
下記表1に示す5成分を共通添加成分として使用し、下記表2に示す配合の透明または半透明化粧水である皮膚化粧料を調製し、下記の方法により評価を行なった。結果を表2に示す。但し、使用した(a)成分の脂肪酸BO付加物は次のようにして調製した。
脂肪酸BO付加物の調製
ラウリン酸821.3g(4.1モル)にテトラメチルアンモニウムクロライド1.8g(対脂肪酸0.4モル%)を3リットル容4つ口フラスコに秤り取り100℃に加熱してから、1,2−ブチレンオキシド375.4g(5.2モル)を徐々に滴下(約3時間)して還流状態にて常圧で反応させた。滴下終了後100℃〜135℃にて加熱還流させながら7時間熟成した。その後、約13kPaで1時間減圧しながらブチレンオキシドを除去してから5%の食塩水246g(対脂肪酸5モル%)で2回水洗して触媒を除去した。さらに、脱水、濾過してラウリン酸ブチレンオキシド付加物(化合物A1)を得た。
上記と同様の条件にてラウリン酸に代えてミリスチン酸934.8g(4.1モル)、ステアリン酸1164.4g(4.1モル)を使用してそれぞれミリスチン酸BO付加物(化合物A2)、ステアリン酸BO付加物(化合物A3)を得た。
Next, the present invention will be described more specifically with reference to examples.
Examples 1 to 3 and Comparative Examples 1 and 2
Using the five components shown in Table 1 as common addition components, skin cosmetics that are transparent or translucent lotions formulated as shown in Table 2 below were prepared and evaluated by the following methods. The results are shown in Table 2. However, the fatty acid BO adduct of component (a) used was prepared as follows.
Preparation of fatty acid BO adduct: 821.3 g (4.1 mol) of lauric acid and 1.8 g of tetramethylammonium chloride (0.4 mol% of fatty acid) were weighed in a 3 liter four-necked flask and heated to 100 ° C. Then, 375.4 g (5.2 mol) of 1,2-butylene oxide was gradually added dropwise (about 3 hours), and the reaction was carried out at reflux under normal pressure. After completion of the dropwise addition, the mixture was aged for 7 hours while being heated to reflux at 100 to 135 ° C. Thereafter, butylene oxide was removed while reducing the pressure at about 13 kPa for 1 hour, and then washed twice with 246 g of 5% brine (5 mol% of fatty acid) to remove the catalyst. Furthermore, dehydration and filtration were performed to obtain a lauric acid butylene oxide adduct (Compound A1).
Myristic acid BO adduct (Compound A2) using 934.8 g (4.1 mol) of myristic acid and 1164.4 g (4.1 mol) of stearic acid instead of lauric acid under the same conditions as above, A stearic acid BO adduct (Compound A3) was obtained.
(1)使用時の感触
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料を使用した時の感触について下記のように判定し、20名の平均値を求めて、平均値1.5点以上を使用時の感触の軽い化粧料であると評価した。
2点:使用時に肌へののびが良くべたつきも無く軽い感触であると感じた場合。
1点:使用時にややのびが悪いもしくはややべたつきが有り若干重い感触であると感 じた場合。
0点:使用時に肌へののびが悪いもしくはべたつきが有り重い感触であると感じた場合 。
(2)使用後のべたつき
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料を使用して10分後の肌の感触について下記のように判定し、20名の平均値を求めて、平均値1.5点以上を使用後にべたつきがない化粧料であると評価した。
2点:肌がべたつきが無いと感じた場合。
1点:肌がややべたつくと感じた場合。
0点:肌が非常にべたつくと感じた場合。
(1) Feeling at the time of use 20 women (21 to 35 years old) are panelists, and the skin feel is used as follows after washing the face, and the average value of 20 people is obtained. The average value of 1.5 points or more was evaluated as a light-weight cosmetic when used.
2 points: When used, the skin feels good and feels light without stickiness.
1 point: When feeling slightly uncomfortable or slightly sticky during use.
0 points: When the skin feels bad or sticky during use and feels heavy.
(2) Stickiness after use 20 women (21-35 years old) are panelists, and after washing their face, using skin cosmetics, the skin feel after 10 minutes is determined as follows. An average value was obtained, and an average value of 1.5 points or more was evaluated as a cosmetic without stickiness after use.
2 points: When the skin feels non-sticky.
1 point: When the skin feels somewhat sticky.
0 points: When the skin feels very sticky.
(3)保湿効果の持続性
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料を使用して2時間後の肌のうるおいについて下記のように判定し、20名の平均値を求めて、平均値1.5点以上を保湿効果の持続性の良好な化粧料であると評価した。
2点:使用直後と変わらず肌が十分うるおっていると感じた場合。
1点:使用直後と比べてやや肌のうるおっていが足りないと感じた場合。
0点:使用直後と比べて明らかに肌のうるおいが足りないと感じた場合。
(4)肌荒れ改善効果
肌荒れを生じた10名の女性(24才〜34才)をパネラーとし、皮膚化粧料を一日2回ずつ連続2週間使用した時の肌の状態について官能で下記のように判定し、20名の平均値を求めて、平均値1.5点以上を肌荒れ改善効果のある化粧料であると評価した。
2点:肌荒れが明らかに治ってきたと感じた場合。
1点:肌荒れがやや治ってきたと感じた場合。
0点:肌荒れ改善効果が全く見られないと感じた場合。
(3) Persistence of moisturizing effect 20 females (21 to 35 years old) are panelists, and after washing their face, using the skin cosmetics, the skin moisture after 2 hours is determined as follows. The average value of 1.5 was evaluated as a cosmetic material having a good moisturizing effect.
2 points: When the skin feels sufficiently moistened just after use.
1 point: When you feel that the skin is slightly damp compared to immediately after use.
0 point: When it feels that the moisture of the skin is clearly insufficient compared with immediately after use.
(4) Skin Roughness Improvement Effect 10 skinny females (24 to 34 years old) are panelists, and the skin condition when using skin cosmetics twice a day for two consecutive weeks is sensuously as follows The average value of 20 people was determined, and an average value of 1.5 points or more was evaluated as a cosmetic having an effect of improving skin roughness.
2 points: When it is felt that rough skin has been cured.
1 point: When it feels that the rough skin has been cured somewhat.
0 point: When it feels that the rough skin improvement effect is not seen at all.
(5)しわ抑制効果
20名の女性(21才〜35才)をパネラーとし、皮膚化粧料を一日2回ずつ連続2週間使用した時の肌の状態について官能で下記のように判定し、20名の平均値を求めて、平均値1.5点以上をしわ抑制効果に優れた化粧料であると評価した。
2点:しわが明らかに目立たなくなったと感じた場合。
1点:しわがやや目立たなくなったと感じた場合。
0点:しわ抑制効果が全く無いと感じた場合。
(6)肌のはり
20名の女性(21才〜35才)をパネラーとし、皮膚化粧料を一日2回ずつ連続2週間使用した時の肌の状態について官能で下記のように判定し、20名の平均値を求めて、平均値1.5点以上を肌にはりを与える効果のある化粧料であると評価した。
2点:明らかに肌にはりがでたと感じた場合。
1点:やや肌にはりがでたと感じた場合。
0点:肌にはりがでないと感じた場合。
(5) Wrinkle suppression effect 20 women (21 to 35 years old) are panelists, and the skin condition when skin cosmetics are used twice a day for two consecutive weeks is determined sensorially as follows: An average value of 20 people was obtained, and an average value of 1.5 points or more was evaluated as a cosmetic excellent in wrinkle suppression effect.
2 points: When wrinkles are clearly inconspicuous.
1 point: When wrinkles are slightly inconspicuous.
0 point: When it feels that there is no wrinkle suppression effect.
(6) Skin tension 20 women (21 to 35 years old) are panelists, and the skin condition when skin cosmetics are used twice a day for two consecutive weeks is determined sensorially as follows: An average value of 20 people was obtained, and an average value of 1.5 points or more was evaluated as a cosmetic having an effect of giving a skin tone.
2 points: When the skin is clearly felt.
1 point: When it feels that the skin has a little bit.
0 points: When the skin feels non-sticky.
(7)経時安定性
化粧料を透明ガラス容器に密封して0℃、25℃、40℃で3ヶ月間保存し、その外観を観察して、下に示す3段階で評価した。
○:安定性良好(いずれの温度においても外観の変化がない。)
△:安定性やや不良(いずれかの温度において若干おり、沈殿を生じるまたは若干 着色を生じる。)
×:安定性不良(いずれかの温度においており、沈殿を生じるまたは分離する。も しくは着色が著しい。)
(7) Stability over time The cosmetic was sealed in a transparent glass container and stored at 0 ° C., 25 ° C. and 40 ° C. for 3 months. The appearance was observed and evaluated in the following three stages.
○: Good stability (no change in appearance at any temperature)
Δ: Slightly poor (slightly at any temperature, causing precipitation or slight coloration)
×: Stability failure (At any temperature, precipitation occurs or separates, or coloring is significant)
実施例1〜3の化粧水はいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。一方、比較例1、2の化粧水では十分な性能が得られていない。つまり、比較例1では(a)成分が配合されていないことから、肌荒れ改善効果、しわ抑制効果が弱くなっており、比較例2では(b)成分が配合されていないことから肌荒れ改善効果、しわ抑制効果、保湿効果の持続性が悪くなっている。 All of the skin lotions of Examples 1 to 3 have a good feel when used and are not sticky after use, have excellent moisturizing effect, excellent skin roughness improvement effect, wrinkle suppression effect and give skin elasticity, stable over time It was also excellent in performance. On the other hand, sufficient performance is not obtained with the lotions of Comparative Examples 1 and 2. That is, in Comparative Example 1, since the component (a) is not blended, the rough skin improvement effect and the wrinkle suppression effect are weak. In Comparative Example 2, since the component (b) is not blended, the rough skin improvement effect, Sustainability of wrinkle suppression effect and moisturizing effect is getting worse.
実施例4〜6、比較例3、4
下記表3に示す13成分を共通添加成分として使用し、下記表4に示す配合の水中油型乳液である皮膚化粧料を調製し、実施例1〜3と同様の方法により評価を行なった。結果を表4に示す。但し、脂肪酸BO付加物は実施例1〜3で使用したものと同様のものを使用した。
Examples 4 to 6, Comparative Examples 3 and 4
Using the 13 components shown in Table 3 as a common additive component, skin cosmetics that are oil-in-water emulsions having the formulations shown in Table 4 below were prepared and evaluated in the same manner as in Examples 1 to 3. The results are shown in Table 4. However, the fatty acid BO adduct was the same as that used in Examples 1-3.
実施例4〜6の乳液はいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。一方、比較例3、4の乳液では十分な性能が得られていない。つまり、比較例3では(a)成分と(b)成分の配合比が本発明の範囲より小さいことから、肌荒れ改善効果、しわ抑制効果が弱くなっており、比較例4では(a)成分と(b)成分の配合比が本発明の範囲より大きいことから使用時の感触が悪くなるとともに保湿効果の持続性が弱くなっている。 All of the emulsions of Examples 4 to 6 have a good feel during use and are not sticky after use, have excellent moisturizing effect, excellent skin roughness improvement effect, wrinkle suppression effect and give skin elasticity, stability over time It was also excellent. On the other hand, sufficient performance is not obtained with the emulsions of Comparative Examples 3 and 4. That is, in Comparative Example 3, since the blending ratio of the component (a) and the component (b) is smaller than the range of the present invention, the rough skin improving effect and the wrinkle suppressing effect are weak. In Comparative Example 4, the component (a) Since the blending ratio of the component (b) is larger than the range of the present invention, the feeling during use is deteriorated and the durability of the moisturizing effect is weakened.
実施例7、8
下記表5に示す11成分を共通添加成分として使用し、下記表6に示す配合の水中油型クリームである皮膚化粧料を調製し、実施例1〜3と同様にして評価を行った。結果を表6に示す。この際、(1)〜(6)の各々の性能については実施例1〜3と同様の方法により、そして(7)経時安定性については下記の方法により評価を行なった。但し、脂肪酸BO付加物は実施例1〜3で使用したものと同様のものを使用した。
Examples 7 and 8
Using 11 components shown in Table 5 as a common additive component, skin cosmetics that are oil-in-water creams having the composition shown in Table 6 below were prepared and evaluated in the same manner as in Examples 1 to 3. The results are shown in Table 6. At this time, each performance of (1) to (6) was evaluated by the same method as in Examples 1 to 3, and (7) stability over time was evaluated by the following method. However, the fatty acid BO adduct was the same as that used in Examples 1-3.
(7−2)経時安定性
化粧料を透明ガラス容器に密封して−5℃、25℃、45℃で1ヶ月間保存したときの状態を調査し、下に示す3段階で評価した。
○:安定性良好(いずれの温度においても外観の変化がなくブツ等も生じない。)
△:安定性やや不良(いずれかの温度において僅かに沈殿を生じるか僅かに分離が 見られる。または僅かにブツ、ダマを生じている。)
×:安定性不良(いずれかの温度において明らかに沈殿を生じるか分離する。または ブツやダマを生じる。)
(7-2) Stability over time The state when the cosmetic was sealed in a transparent glass container and stored at −5 ° C., 25 ° C., and 45 ° C. for 1 month was evaluated and evaluated in the following three stages.
○: Stability is good (no change in appearance at any temperature and no flickering etc.)
Δ: Slightly inferior (slight precipitation or slight separation at any temperature, or slight bumps and lumps)
×: Stability is poor (clearly precipitates or separates at any temperature, or produces lumps and lumps)
実施例7、8のクリームはいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。
実施例9、10
下記表7に示す10成分を共通添加成分として使用し、上記表6に示す配合の油中水型クリームである皮膚化粧料を調整し、実施例7、8と同様の方法により評価を行なった。結果を表6に示す。但し、脂肪酸BO付加物は実施例1〜3で使用したものと同じものを使用した。
Each of the creams of Examples 7 and 8 has a good feel during use and is not sticky after use, has an excellent moisturizing effect, an excellent skin roughening effect, an excellent wrinkle-suppressing effect and gives skin elasticity, and is stable over time. It was also excellent.
Examples 9, 10
10 components shown in Table 7 below were used as common additive components, skin cosmetics that were water-in-oil creams with the formulations shown in Table 6 were prepared, and evaluation was performed in the same manner as in Examples 7 and 8. . The results are shown in Table 6. However, the same fatty acid BO adduct as that used in Examples 1 to 3 was used.
実施例9、10のクリームはいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。 Each of the creams of Examples 9 and 10 has a good feel during use and is not sticky after use, has excellent moisturizing effect, has excellent skin roughness improvement effect, wrinkle suppression effect, gives skin elasticity, and is stable over time. It was also excellent.
本発明は化粧水、乳液、クリーム、パック、ヘアトニック等の皮膚用の化粧料に利用することができる。
The present invention can be used for skin cosmetics such as lotions, emulsions, creams, packs, and hair tonics.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003339024A JP4529402B2 (en) | 2003-09-30 | 2003-09-30 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003339024A JP4529402B2 (en) | 2003-09-30 | 2003-09-30 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005104884A JP2005104884A (en) | 2005-04-21 |
JP4529402B2 true JP4529402B2 (en) | 2010-08-25 |
Family
ID=34534321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003339024A Expired - Lifetime JP4529402B2 (en) | 2003-09-30 | 2003-09-30 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4529402B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4715186B2 (en) * | 2003-12-15 | 2011-07-06 | 日油株式会社 | Thickener and detergent composition for surfactant |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62197499A (en) * | 1986-02-25 | 1987-09-01 | ライオン株式会社 | Softener composition |
JPS6368510A (en) * | 1986-09-09 | 1988-03-28 | Nippon Oil & Fats Co Ltd | Plaster for sheet-like pack |
JPS63107740A (en) * | 1986-10-23 | 1988-05-12 | Pola Chem Ind Inc | Preparation of oil-in-water-type emulsion |
JPH02149335A (en) * | 1988-11-30 | 1990-06-07 | Nippon Oil & Fats Co Ltd | Chitosan-gelatine crosslinking gel |
JPH0338508A (en) * | 1989-07-04 | 1991-02-19 | Kobayashi Kose Co Ltd | Water-based cosmetic |
JPH07138136A (en) * | 1993-11-22 | 1995-05-30 | Kao Corp | Hair-shampooing agent composition |
JPH08283123A (en) * | 1995-04-10 | 1996-10-29 | Kao Corp | Aqueous gellike detergent composition |
JPH0940525A (en) * | 1995-07-28 | 1997-02-10 | Kao Corp | Water-based detergent composition |
JPH1053795A (en) * | 1996-08-09 | 1998-02-24 | Kao Corp | Detergent composition |
JPH1095707A (en) * | 1996-09-20 | 1998-04-14 | Kose Corp | Oil-in-water type cosmetic |
JP2000256173A (en) * | 1999-03-15 | 2000-09-19 | Kose Corp | Emulsified cosmetic |
JP2000325771A (en) * | 1999-05-17 | 2000-11-28 | Nof Corp | Emulsifier for cosmetics and cosmetics containing the same |
JP2001334139A (en) * | 2000-05-30 | 2001-12-04 | Nof Corp | Surfactant and detergent composition containing the same |
JP2002284672A (en) * | 2001-03-28 | 2002-10-03 | Kose Corp | Cleansing cosmetics |
JP2003221310A (en) * | 2001-11-21 | 2003-08-05 | Shiseido Co Ltd | Skin cleanser |
-
2003
- 2003-09-30 JP JP2003339024A patent/JP4529402B2/en not_active Expired - Lifetime
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62197499A (en) * | 1986-02-25 | 1987-09-01 | ライオン株式会社 | Softener composition |
JPS6368510A (en) * | 1986-09-09 | 1988-03-28 | Nippon Oil & Fats Co Ltd | Plaster for sheet-like pack |
JPS63107740A (en) * | 1986-10-23 | 1988-05-12 | Pola Chem Ind Inc | Preparation of oil-in-water-type emulsion |
JPH02149335A (en) * | 1988-11-30 | 1990-06-07 | Nippon Oil & Fats Co Ltd | Chitosan-gelatine crosslinking gel |
JPH0338508A (en) * | 1989-07-04 | 1991-02-19 | Kobayashi Kose Co Ltd | Water-based cosmetic |
JPH07138136A (en) * | 1993-11-22 | 1995-05-30 | Kao Corp | Hair-shampooing agent composition |
JPH08283123A (en) * | 1995-04-10 | 1996-10-29 | Kao Corp | Aqueous gellike detergent composition |
JPH0940525A (en) * | 1995-07-28 | 1997-02-10 | Kao Corp | Water-based detergent composition |
JPH1053795A (en) * | 1996-08-09 | 1998-02-24 | Kao Corp | Detergent composition |
JPH1095707A (en) * | 1996-09-20 | 1998-04-14 | Kose Corp | Oil-in-water type cosmetic |
JP2000256173A (en) * | 1999-03-15 | 2000-09-19 | Kose Corp | Emulsified cosmetic |
JP2000325771A (en) * | 1999-05-17 | 2000-11-28 | Nof Corp | Emulsifier for cosmetics and cosmetics containing the same |
JP2001334139A (en) * | 2000-05-30 | 2001-12-04 | Nof Corp | Surfactant and detergent composition containing the same |
JP2002284672A (en) * | 2001-03-28 | 2002-10-03 | Kose Corp | Cleansing cosmetics |
JP2003221310A (en) * | 2001-11-21 | 2003-08-05 | Shiseido Co Ltd | Skin cleanser |
Also Published As
Publication number | Publication date |
---|---|
JP2005104884A (en) | 2005-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4670366B2 (en) | Skin cosmetics | |
JP5093998B2 (en) | Pigmentation preventing or improving agent | |
JP5550863B2 (en) | Cosmetics | |
JP5002434B2 (en) | Emulsifying bath composition | |
JP5766258B2 (en) | Pigmentation preventing or improving agent | |
JP6530236B2 (en) | Skin cream | |
JP2014532674A (en) | Cosmetic composition | |
JP4841075B2 (en) | Whitening cosmetics | |
JP6639816B2 (en) | Cosmetics | |
JP4123028B2 (en) | Skin cosmetics | |
KR20060058630A (en) | Skin cosmetics | |
JP6376835B2 (en) | Topical skin preparation | |
JP6747763B2 (en) | Emulsified cosmetics | |
JP4529402B2 (en) | Skin cosmetics | |
JP2005281253A (en) | Skin cosmetic | |
JP3931295B2 (en) | Emulsified cosmetic for hairdressing | |
JP2000344697A (en) | Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol | |
WO2019151275A1 (en) | Method for improving stickiness of adenosine-phosphate-containing composition | |
JP5494141B2 (en) | Topical skin preparation | |
JP5777859B2 (en) | Emulsified composition | |
JP6870917B2 (en) | Topical composition | |
JP4815060B2 (en) | Oil agent and cosmetic and external preparation containing the same | |
JPH08268866A (en) | Dermal preparation for external use | |
JP2000191499A (en) | Cosmetic for moisturiztng skin | |
JP2004244319A (en) | Cosmetic and external preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060904 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100416 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100518 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100531 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4529402 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130618 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140618 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |